180 related articles for article (PubMed ID: 31524146)
41. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
[TBL] [Abstract][Full Text] [Related]
42. Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer.
Nagasawa S; Tsuchida K; Shiozawa M; Hiroshima Y; Kimura Y; Hashimoto I; Watanabe H; Kano K; Numata M; Aoyama T; Sato S; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Morinaga S; Yukawa N; Rino Y; Masuda M; Saeki H; Miyagi Y; Oshima T
Anticancer Res; 2021 Sep; 41(9):4489-4495. PubMed ID: 34475074
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
Yu MH; Luo Y; Qin SL; Zhong M
Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
[TBL] [Abstract][Full Text] [Related]
44. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
45. Differential CXC receptor expression in colorectal carcinomas.
Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
[TBL] [Abstract][Full Text] [Related]
46. CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1.
Kollmar O; Rupertus K; Scheuer C; Nickels RM; Haberl GC; Tilton B; Menger MD; Schilling MK
Int J Cancer; 2010 Mar; 126(6):1302-15. PubMed ID: 19821487
[TBL] [Abstract][Full Text] [Related]
47. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer.
Li QG; Xu XQ; Zhou DY; Jia ZB; Yu BF; Xu FG; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3320-3325. PubMed ID: 31081085
[TBL] [Abstract][Full Text] [Related]
49. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
50. CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
Moreno MJ; Gallardo A; Novelli S; Mozos A; Aragó M; Pavón MÁ; Céspedes MV; Pallarès V; Falgàs A; Alcoceba M; Blanco O; Gonzalez-Díaz M; Sierra J; Mangues R; Casanova I
PLoS One; 2018; 13(6):e0198789. PubMed ID: 29920526
[TBL] [Abstract][Full Text] [Related]
51. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
52. High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
Yang P; Wei J; Li W; He F; Zeng S; Zhang T; Sun Z; Cao J
Biotechnol Lett; 2016 Jun; 38(6):1043-7. PubMed ID: 26965150
[TBL] [Abstract][Full Text] [Related]
53. Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Desnoyer A; Dupin N; Assoumou L; Carlotti A; Gaudin F; Deback C; Peytavin G; Marcelin AG; Boué F; Balabanian K; Pourcher V;
Br J Dermatol; 2016 Dec; 175(6):1251-1262. PubMed ID: 27177037
[TBL] [Abstract][Full Text] [Related]
54. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
55. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
[TBL] [Abstract][Full Text] [Related]
56. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
[TBL] [Abstract][Full Text] [Related]
58. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.
Wang B; Wang W; Niu W; Liu E; Liu X; Wang J; Peng C; Liu S; Xu L; Wang L; Niu J
Carcinogenesis; 2014 Feb; 35(2):282-91. PubMed ID: 24085800
[TBL] [Abstract][Full Text] [Related]
59. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
[TBL] [Abstract][Full Text] [Related]
60. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
